G&E Herbal Biotechnology Dividends and Buybacks
Dividend criteria checks 3/6
G&E Herbal Biotechnology is a dividend paying company with a current yield of 0.97% that is well covered by earnings.
Key information
1.0%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | 48.1% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | NT$0.538 |
| Payout ratio | 38% |
Recent dividend and buyback updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 4911's dividend payments have been volatile in the past 10 years.
Growing Dividend: 4911's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| G&E Herbal Biotechnology Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (4911) | 1.0% |
| Market Bottom 25% (TW) | 1.7% |
| Market Top 25% (TW) | 4.5% |
| Industry Average (Personal Products) | 4.7% |
| Analyst forecast (4911) (up to 3 years) | n/a |
Notable Dividend: 4911's dividend (0.97%) isn’t notable compared to the bottom 25% of dividend payers in the TW market (1.74%).
High Dividend: 4911's dividend (0.97%) is low compared to the top 25% of dividend payers in the TW market (4.48%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (37.9%), 4911's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (24.6%), 4911's dividend payments are well covered by cash flows.